Effect of Sequence and Stereochemistry Reversal on p53 Peptide Mimicry

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Atzori, Alessio ^a   Baker, Audrey E ^b   Chiu, Mark ^b   Bryce, Richard A ^a   Bonnet, Pascal ^b,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^c UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDOMIMETIC AGENT; PROTEIN MDM2; PROTEIN P53; SOLVENT; WATER;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ARTICLE; CHEMICAL MODIFICATION; CIRCULAR DICHROISM; CONTROLLED STUDY; MOLECULAR DYNAMICS; MOLECULAR MIMICRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDE ANALYSIS; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STEREOCHEMISTRY;

EID: 84880797129     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068723     Document Type: Article

References (29)

1. Cohen FE, Prusiner SB, (1998) Pathologic conformations of prion proteins. Annu Rev Biochem 67: 793-819.
2. Loregian A, Marsden HS, Palu G, (2002) Protein-protein interactions as targets for antiviral chemotherapy. Rev Med Virol 12: 239-262.
3. Selkoe DJ, (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8: 447-453.
4. Verdine GL, Walensky LD, (2007) The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members. Clin Cancer Res 13: 7264-7270.
5. Giannis A, Rübsam F, (1997) Peptidomimetics in drug design. Adv Drug Res 29: 1-78.
6. Grauer A, König B, (2009) Peptidomimetics- A Versatile Route to Biologically Active Compounds. Eur J Org Chem 2009: 5099-5111.
7. Goodman M, Chorev M, (1979) Concept of Linear Modified Retro-Peptide Structures. Acc Chem Res 12: 1-7.
8. Chorev M, Goodman M, (1993) A Dozen Years of Retro-Inverso Peptidomimetics. Acc Chem Res 26: 266-273.
9. Rai J, (2007) Retroinverso mimetics of S peptide. Chem Biol Drug Des 70: 552-556.
10. Li C, Pazgier M, Li J, Liu M, Zou G, et al. (2010) Limitations of peptide retro-inverso isomerization in molecular mimicry. J Biol Chem 285: 19572-19581.
11. Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, et al. (1996) Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274: 948-953.
12. Dastidar SG, Lane DP, Verma CS, (2008) Multiple peptide conformations give rise to similar binding affinities: molecular simulations of p53-MDM2. J Am Chem Soc 130: 13514-13515.
13. Guo Z, Mohanty U, Noehre J, Sawyer TK, Sherman W, et al. (2010) Probing the alpha-helical structural stability of stapled p53 peptides: molecular dynamics simulations and analysis. Chem Biol Drug Des 75: 348-359.
14. Sakurai K, Chung HS, Kahne D, (2004) Use of a Retroinverso p53 Peptide as an Inhibitor of MDM2. J Am Chem Soc 126: 16288-16289.
15. Guichard G, Muller S, van Regenmortel M, Briand JP, Mascagni P, et al. (1996) Structural limitations to antigenic mimicry achievable with retroinverso (all-D-retro) peptides. Trends Biotechnol 14: 44-45.
16. Pazgier M, Liu M, Zou G, Yuan W, Li C, et al. (2009) Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX. P Natl Acad Sci U S A 106: 4665-4670.
17. Liu M, Pazgier M, Li C, Yuan W, Lu W, (2010) A left-handed solution to peptide inhibition of the p53-MDM2 interaction. Angew Chem Int Ed Engl 49: 3649-3652.
18. Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, et al. (2006) Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 65: 712-725.
19. Onufriev A, Bashford D, Case DA, (2004) Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins 55: 383-394.
20. Okur A, Wickstrom L, Simmerling C, (2008) Evaluation of salt bridge structure and energetics in peptides using explicit, implicit, and hybrid solvation models. J Chem Theory Comput 4: 488-498.
21. Case DA, Darden TA, III TEC, Simmerling CL, Wang J, et al. (2010) AMBER 11, University of California, San Francisco.
22. Molecular Operating Environment (MOE), 2012.10; Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2012.
23. Bursulaya BD, Brooks CL, (2000) Comparative study of the folding free energy landscape of a three-stranded beta-sheet protein with explicit and implicit solvent models. J Phys Chem B 104: 12378-12383.
24. Sugita Y, Okamoto Y, (1999) Replica-exchange molecular dynamics method for protein folding. Chem Phys Lett 314: 141-151.
25. van der Spoel D, Patriksson A, (2008) A temperature predictor for parallel tempering simulations. Phys Chem Chem Phys 10: 2073-2077.
26. Kabsch W, Sander C, (1983) Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22: 2577-2637.
27. Greenfield N, Fasman GD, (1969) Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry-US 8: 4108-4116.
28. Adler AJ, Greenfield NJ, Fasman GD, (1973) Circular dichroism and optical rotatory dispersion of proteins and polypeptides. Methods Enzymol 27: 675-735.
29. Bohm G, Muhr R, Jaenicke R, (1992) Quantitative analysis of protein far UV circular dichroism spectra by neural networks. Protein Eng 5: 191-195.